Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes

Blood. 2023 Apr 6;141(14):1768-1772. doi: 10.1182/blood.2022018896.

Tariq Kewan^{1

2}, Waled Bahaj¹, Arda Durmaz^{1

3}, Mai Aly^{1

4}, Olisaemeka D Ogbue¹, Hetty E Carraway¹, Mikkael A Sekeres⁵, Valeria Visconte¹, Carmelo Gurnari^{1

6}, Jaroslaw P Maciejewski¹

¹ Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
² Department of Hematology and Oncology, Yale University, New Haven, CT.
³ Systems Biology and Bioinformatics Department, School of Medicine, Case Western Reserve University, Cleveland, OH.
⁴ Faculty of Medicine, Assiut University, Assiut, Egypt.
⁵ Department of Hematology and Oncology, University of Miami, Miami, FL.
⁶ Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.

No abstract available

MeSH terms